ADC’s Journey – Enhancing Translatability by Bridging Preclinical & Clinical Data

Time: 12:20 pm
day: Day Two

Details:

  • Evaluating in vivo models for clinical design
  • PDX and organoids to support dosing decision and efficacy evidence
  • Addressing toxicity issues to ensure safety profiling
  • Data package for successful filing

Speakers: